Fractional Change in Apparent Diffusion Coefficient as an Imaging Biomarker for Predicting Treatment Response in Head and Neck Cancer Treated with Chemoradiotherapy

References

1. 1.↵
   1. Argiris A,
   2. Karamouzis MV,
   3. Raben D,
   4. et al

   . Head and neck cancer. Lancet 2008;371:1695–709

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Horiot JC,
   2. Bontemps P,
   3. van den Bogaert W,
   4. et al

   . Accelerated fractionation (AF) compared with conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111–21

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Ang KK,
   2. Tortti A,
   3. Brown BW,
   4. et al

   . Randomized trial addressing risk feature and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;51:571–78

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Chiesa F,
   2. Mauri S,
   3. Tradati N,
   4. et al

   . Surfing prognostic factors in head and neck cancer at the millennium. Oral Oncol 1999;35:590–96

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Chenevert TL,
   2. Stegman LD,
   3. Taylor JM,
   4. et al

   . Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029–36

   Abstract/FREE Full Text
6. 6.↵
   1. Kim S,
   2. Loevner L,
   3. Quon H,
   4. et al

   . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986–94

   Abstract/FREE Full Text
7. 7.↵
   1. Hatakenaka M,
   2. Nakamura K,
   3. Yabuuchi H,
   4. et al

   . Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:339–45

   CrossRefPubMed
8. 8.↵
   1. Vandecaveye V,
   2. Dirix P,
   3. De Keyzer F,
   4. et al

   . Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20:1703–14

   CrossRefPubMed
9. 9.↵
   1. King AD,
   2. Mo FK,
   3. Yu KH,
   4. et al

   . Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20:2213–20

   CrossRefPubMed
10. 10.↵
    1. Vandecaveye V,
    2. Dirix P,
    3. Keyzer FD,
    4. et al

    . Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012;82:1098–107

    CrossRefPubMed
11. 11.↵
    1. Kato H,
    2. Kanematsu M,
    3. Tanaka O,
    4. et al

    . Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect. Eur Radiol 2009;19:103–09

    CrossRefPubMed
12. 12.↵
    1. Hamstra DA,
    2. Rehemtulla A,
    3. Ross BD

    . Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007;25:4104–09

    Abstract/FREE Full Text
13. 13.↵
    1. Roth Y,
    2. Tichler T,
    3. Kostenich G,
    4. et al

    . High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004;232:685–92

    CrossRefPubMed
14. 14.↵
    1. Hamstra DA,
    2. Lee KC,
    3. Moffat BA,
    4. et al

    . Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotheray in a mouse model of squamous cell cancer of head and neck. Transl Oncol 2008;1:187–94

    PubMed
15. 15.↵
    1. Padhani AR,
    2. Liu G,
    3. Koh DM,
    4. et al

    . Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102–25

    PubMedWeb of Science
16. 16.↵
    1. Moffat BA,
    2. Chenevert TL,
    3. Lawrence TS,
    4. et al

    . Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102:5524–29

    Abstract/FREE Full Text
17. 17.↵
    1. Galbán CJ,
    2. Mukherji SK,
    3. Chenevert TL,
    4. et al

    . A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2:184–90

    PubMed
18. 18.↵
    1. Koh DM,
    2. Collins DJ

    . Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622–35

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Chung EJ,
    2. Lee NJ,
    3. Baek SK,
    4. et al

    . Clinical efficacy of primary tumor volume measurements: comparison of different primary sites. Clin Exp Otorhinolaryngol 2009;2:78–84

    CrossRefPubMed
20. 20.↵
    1. Pignon JP,
    2. Bourhis J,
    3. Designe L

    . Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949–55

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Lango MN,
    2. Myers JN,
    3. Garden AS

    . Controversies in surgical management of the node-positive neck after chemoradiation. Semin Radiat Oncol 2009;19:24–28

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Labadie RF,
    2. Yarbrough WG,
    3. Weissler MC,
    4. et al

    . Nodal volume reduction after concurrent chemo- and radiotherapy: correlation between initial CT and histopathologic findings. AJNR Am J Neuroradiol 2000;21:310–14

    Abstract/FREE Full Text
23. 23.↵
    1. Clavel S,
    2. Charron MP,
    3. Belair M,
    4. et al

    . The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012;82:567–73

    CrossRefPubMed
24. 24.↵
    1. Fakhry C,
    2. Westra WH,
    3. Li S,
    4. et al

    . Improved survival of patients with human papillomavirus: positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–69

    Abstract/FREE Full Text